Pharma & Health Cyber Sec 2026 is a premier India-focused industry platform bringing together cybersecurity leaders, healthcare providers, pharmaceutical companies, biotech innovators, healthtech start-ups, IT solution providers, regulators, insurers and compliance experts. The conference addresses the rapidly evolving cyber threat landscape across India's healthcare, pharmaceutical and life sciences markets, while enabling collaboration, knowledge exchange and the adoption of best practices that strengthen cyber resilience across the ecosystem.

India's healthcare and pharmaceutical sector is undergoing rapid digital expansion — driven by nationwide adoption of electronic health records (EHRs), telemedicine platforms, Ayushman Bharat Digital Mission (ABDM) initiatives, connected medical devices, cloud computing, AI, digital therapeutics and smart pharmaceutical manufacturing under Industry 4.0. This growth has also significantly expanded cyber risk exposure — from ransomware attacks on hospitals and patient data breaches, to IP theft from R&D centers and supply chain vulnerabilities in drug manufacturing.

The Indian healthcare and pharmaceutical industries manage highly sensitive, high-value data assets — patient health information, clinical trial datasets, genomic research, drug formulations, manufacturing process data and proprietary innovation pipelines. A single cyber incident can lead to operational downtime in hospitals, compromise patient safety, delay drug approvals and clinical trials, and cause significant financial, regulatory and reputational impact across domestic and global markets.

As India strengthens its digital healthcare ecosystem and expands its global pharmaceutical footprint, organizations must adopt proactive, scalable and compliance-driven cybersecurity strategies. Pharma & Health Cyber Sec 2026 serves as a strategic market platform to explore emerging cyber risks, regulatory frameworks, investment opportunities and India-specific cybersecurity solutions that enable a safer, more resilient, innovation-driven healthcare and pharma industry.